Showing results for: "receptor agonists" (18 results)
Explore the multi-organ cellular mapping of GLP-1 receptor agonists. Discover how GLP-1RAs act as a systemic shield across T2DM, obesity, PMOS, MASH and so on.
Environmental endocrine disruptors (EEDs) are natural and synthetic chemicals that interfere with endocrine system function by altering hormone synthesis, transport, metabolism, and receptor binding.
Discover why medical experts are rebranding Polycystic Ovary Syndrome (PCOS) to PMOS, and what this metabolic shift means for patient wellness.
What does stress actually do to your body? Explore the neurobiology of the survival response, from the immediate SAM axis to the the HPA axis, and learn how to restore your biological equilibrium.
Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.
The current trajectory of epilepsy management has encountered a formidable "refractory wall." Despite the accelerated expansion of the neuropharmacological pharmacopeia,
Cell and gene therapies represent a seismic shift in healthcare. They promise to cure the incurable, restoring sight to the blind and erasing cancer from the blood. But this frontier is wild. It comes with biological price tags, potential genetic misfires, and a regulatory landscape that is still being mapped.
Bacterial lysates and postbiotics can train your immune system to prevent respiratory infections. Here is why they matter in the era of antibiotic resistance.
Ever wonder what it’s like if a tiny chip could detect cancer before symptoms appear. Biosensor technology is transforming cancer detection- earlier, faster and more accessible for people worldwide
Natural polysaccharides like locust bean gum and chitosan are replacing lactose as safer, more effective carriers for inhaled medications and vaccines.
The tumor microenvironment (TME) is a complex and dynamic ecosystem composed of malignant cells, immune infiltrates, stromal elements, and vascular components that collectively influence tumor initiation, progression, immune escape, and therapeutic response. Traditional bulk transcriptomic approaches obscure this complexity by averaging gene expression across heterogeneous cell populations.
Drug repurposing is reshaping medicine. Discover how changing a drug's route of administration — not the molecule itself — can unlock new therapeutic potential.
Cells constantly sense signals from their environment and convert them into internal actions through biochemical signalling pathways.
What if one of the most powerful models for understanding the human brain were less than an inch long, transparent, and living in a small tank? Meet Danio rerio, the zebrafish.
Disorders of Gut–Brain Interaction (DGBIs), such as Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS), present a formidable clinical impasse due to their profoundly heterogeneous and multifactorial nature.
Too big, it hits your throat. Too small, you exhale it. The sweet spot delivers drugs exactly where they're needed.
Professional cycling is a sport defined by marginal gains. At the highest levels of competition, the difference between victory and the middle of the pack can be measured in seconds, watts, or subtle physiological advantages accumulated over months of preparation.
Tiny but powerful, basement membranes support cells, regulate barriers, and drive disease when disrupted—key players in health, aging, and cancer.
